Literature DB >> 10873446

Peptide inhibitors of DNA cleavage by tyrosine recombinases and topoisomerases.

M Klemm1, C Cheng, G Cassell, S Shuman, A M Segall.   

Abstract

The study of biochemical pathways requires the isolation and characterization of each and every intermediate in the pathway. For the site-specific recombination reactions catalyzed by the bacteriophage lambda tyrosine recombinase integrase (Int), this has been difficult because of the high level of efficiency of the reaction, the highly reversible nature of certain reaction steps, and the lack of requirements for high-energy cofactors or metals. By screening synthetic peptide combinatorial libraries, we have identified two related hexapeptides, KWWCRW and KWWWRW, that block the strand-cleavage activity of Int but not the assembly of higher-order intermediates. Although the peptides bind DNA, their inhibitory activity appears to be more specifically targeted to the Int-substrate complex, insofar as inhibition is resistant to high levels of non-specific competitor DNA and the peptides have higher levels of affinity for the Int-DNA substrate complex than for DNA alone. The peptides inhibit the four pathways of Int-mediated recombination with different potencies, suggesting that the interactions of the Int enzyme with its DNA substrates differs among pathways. The KWWCRW and KWWWRW peptides also inhibit vaccinia virus topoisomerase, a type IB enzyme, which is mechanistically and structurally related to Int. The peptides differentially affect the forward and reverse DNA transesterification steps of the vaccinia topoisomerase. They block formation of the covalent vaccinia topoisomerase-DNA intermediate, but have no apparent effect on DNA religation by preformed covalent complexes. The peptides also inhibit Escherichia coli topoisomerase I, a type IA enzyme. Finally, the peptides inhibit the bacteriophage T4 type II topoisomerase and several restriction enzymes with 2000-fold lower potency than they inhibit integrase in the bent-L pathway. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873446     DOI: 10.1006/jmbi.2000.3829

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  22 in total

1.  Potent antimicrobial small molecules screened as inhibitors of tyrosine recombinases and Holliday junction-resolving enzymes.

Authors:  Marc C Rideout; Jeffrey L Boldt; Gabriel Vahi-Ferguson; Peter Salamon; Adel Nefzi; John M Ostresh; Marc Giulianotti; Clemencia Pinilla; Anca M Segall
Journal:  Mol Divers       Date:  2011-09-22       Impact factor: 2.943

2.  Holliday junction-binding peptides inhibit distinct junction-processing enzymes.

Authors:  Kevin V Kepple; Jeffrey L Boldt; Anca M Segall
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-02       Impact factor: 11.205

3.  New peptide inhibitors of type IB topoisomerases: similarities and differences vis-a-vis inhibitors of tyrosine recombinases.

Authors:  David F Fujimoto; Clemencia Pinilla; Anca M Segall
Journal:  J Mol Biol       Date:  2006-08-24       Impact factor: 5.469

4.  A biotin interference assay highlights two different asymmetric interaction profiles for lambda integrase arm-type binding sites in integrative versus excisive recombination.

Authors:  Dane Hazelbaker; Marco A Azaro; Arthur Landy
Journal:  J Biol Chem       Date:  2008-03-04       Impact factor: 5.157

5.  Peptide wrwycr inhibits the excision of several prophages and traps holliday junctions inside bacteria.

Authors:  Carl W Gunderson; Jeffrey L Boldt; R Nathan Authement; Anca M Segall
Journal:  J Bacteriol       Date:  2009-01-30       Impact factor: 3.490

6.  Small molecule functional analogs of peptides that inhibit lambda site-specific recombination and bind Holliday junctions.

Authors:  Dev K Ranjit; Marc C Rideout; Adel Nefzi; John M Ostresh; Clemencia Pinilla; Anca M Segall
Journal:  Bioorg Med Chem Lett       Date:  2010-06-08       Impact factor: 2.823

7.  Mutations at residues 282, 286, and 293 of phage lambda integrase exert pathway-specific effects on synapsis and catalysis in recombination.

Authors:  Troy M Bankhead; Bernard J Etzel; Felise Wolven; Sylvain Bordenave; Jeffrey L Boldt; Teresa A Larsen; Anca M Segall
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

Review 8.  Orthopoxvirus targets for the development of antiviral therapies.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Curr Drug Targets Infect Disord       Date:  2005-03

Review 9.  The λ Integrase Site-specific Recombination Pathway.

Authors:  Arthur Landy
Journal:  Microbiol Spectr       Date:  2015-04

10.  Control of directionality in the DNA strand-exchange reaction catalysed by the tyrosine recombinase TnpI.

Authors:  Virginie Vanhooff; Christophe Normand; Christine Galloy; Anca M Segall; Bernard Hallet
Journal:  Nucleic Acids Res       Date:  2009-12-30       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.